Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Eyes and Vision

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 0 · 0%Moderate 4 · 66.7%High 0 · 0%

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 641 participants
Moderate

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 487 participants
Moderate

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 640 participants
Moderate

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 2644 participants
Very low

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 2701 participants
Very low

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1592 participants
Moderate